Last reviewed · How we verify
NCT05336929
Roy Adaptation Model in People With Type 1 Diabetes
NA trial testing Roy adaptation model-based nursing education in Type 1 Diabetes in 60 participants. Completed in 31 December 2018.
31 December 2017
Quick facts
| Lead sponsor | Balikesir University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 60 |
| Start date | 1 June 2016 |
| Primary completion | 31 December 2017 |
| Estimated completion | 31 December 2018 |
Drugs / interventions tested
- Roy adaptation model-based nursing education
Conditions studied
- Type 1 Diabetes — all drugs for Type 1 Diabetes →
- Adolescent — all drugs for Adolescent →
Sponsor
Balikesir University
Who can join
Adults 11 to 18, any sex, with Type 1 Diabetes or Adolescent. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study was conducted to determine the effect of Roy adaptation model-based education on disease compliance and metabolic control in adolescents with Type 1 diabetes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05336929
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Type 1 Diabetes
Currently open trials in the same condition.
- NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
- NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
- NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
- NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
- NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting
Other Balikesir University trials
Trials by the same sponsor.
- NCT07048093 — Development of Standard Guidelines for Relaxation Exercises in Patients With Chronic Neck Pain and Determination of Thei · NA · not yet recruiting
- NCT06812481 — Anticholinergic Burden and Osteoporosis in Rheumatoid Arthritis · recruiting
- NCT06856395 — Effect of Using Educational Robots During Vaccination on Fear and Pain in Children · NA · not yet recruiting
- NCT07103837 — Development, Validity, and Reliability of the Reactive Skill Test in Older Adults · NA · completed
- NCT07203924 — Prognostic Importance of Physical Activity in Geriatric Patients With Acute Coronary Syndrome · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05336929 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Balikesir University
- Last refreshed: 20 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05336929.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing